Amount Raised
$70 Million
Round Type
Post-IPO Equity
ZugBiotechnologyHealth CareTherapeuticsDescription
Pharvaris (Nasdaq: PHVS), a clinical-stage company focused on the development and commercialization of novel oral bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin-B2-receptor-mediated indications, today announced that it has entered into a subscription agreement relating to the offer and sale of an aggregate of 6,951,340 ordinary shares of the Company, par value €0.12 per share (the “Ordinary Shares”), in a private placement (the “Offering”) to a group of institutional investors, led by General Atlantic and venBio Partners with participation from Bain Capital Life Sciences, Foresite Capital, and Venrock Healthcare Capital Partners, at an offering price of $10.07 per share, for gross proceeds of approximately $70 million before deducting any offering-related expenses.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Pharvaris that raised within 45 days of this round, from Fundz verified event records.
- Oragenics raised $850K (Series C) on August 4, 2023.
- Ikena Oncology raised $43M on August 4, 2023.
- PredxBio raised $601K (Seed) on August 4, 2023.
- ADARx Pharmaceuticals, Inc. raised $200M on August 2, 2023.
- Solu Therapeutics raised an undisclosed amount (Seed) on August 1, 2023.
- KayoThera, Inc. raised an undisclosed amount (Series A) on July 19, 2023.
Who to call at Pharvaris, and when
A new round usually means Pharvaris is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pharvaris raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pharvaris, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pharvaris. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pharvaris raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Pharvaris raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.